Investment Thesis
Omada Health demonstrates strong revenue growth (53.2% YoY) with exceptional gross margins (62.4%), indicating a sustainable core business model. However, negative operating cash flow (-$11.8M) and operating losses (-$4.8M) indicate the company is not yet executing profitably at scale. The fortress balance sheet ($211.8M cash, zero debt) provides 18-24 months of runway to reach operating breakeven, but trajectory must improve markedly to justify continued cash consumption.
Strengths
- Outstanding gross margin of 62.4% demonstrates pricing power and efficient delivery of healthcare services
- Strong revenue growth of 53.2% YoY in large addressable healthcare market with improving loss trajectory (-3.0M improving 72.9% YoY)
- Fortress balance sheet with $211.8M cash, zero long-term debt, 3.92x current ratio, and equity of $234.1M provides substantial operational runway
Risks
- Negative operating cash flow of -$11.8M indicates company is burning cash operationally despite gross profitability—unsustainable if not corrected within 12-18 months
- Operating margin of -6.1% with $4.8M operating losses suggests operating expenses are growing faster than revenue, indicating poor operating leverage
- Cash depletion trajectory at current burn rate of approximately $11.8M annually would exhaust reserves within 18+ years, but path to positive OCF must be demonstrated soon
Key Metrics to Watch
- Operating cash flow trend - critical inflection point toward positive OCF
- Operating expense ratio as percentage of revenue - must show operating leverage and expense discipline
- Revenue growth sustainability and contribution margin trends by customer segment
Financial Metrics
Revenue
78.0M
Net Income
-3.0M
EPS (Diluted)
$-0.05
Free Cash Flow
-11.9M
Total Assets
302.8M
Cash
211.8M
Profitability Ratios
Gross Margin
62.4%
Operating Margin
-6.1%
Net Margin
-3.8%
ROE
-1.3%
ROA
-1.0%
FCF Margin
-15.3%
Balance Sheet & Liquidity
Current Ratio
3.92x
Quick Ratio
3.87x
Debt/Equity
0.00x
Debt/Assets
22.7%
Interest Coverage
N/A
Long-term Debt
0.0
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-09T12:15:51.513218 |
Data as of: 2026-03-31 |
Powered by Claude AI